Patents by Inventor Jonathan Plassais

Jonathan Plassais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tools for assessing FimH blockers therapeutic efficiency
    Patent number: 11898210
    Abstract: The present invention relates to an in vitro method for identifying subjects hosting high amounts of Fim H expressing proteobacteria in their gut, said method comprising the step of detecting the expression of the fimH gene in a stool sample of said subjects.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: February 13, 2024
    Assignee: ENTEROME
    Inventors: Alessandra Cervino, Christophe Bonny, Jonathan Plassais
  • NEW TOOLS FOR ASSESSING FIMH BLOCKERS THERAPEUTIC EFFICIENCY
    Publication number: 20200277655
    Abstract: The present invention relates to an in vitro method for identifying subjects hosting high amounts of Fim H expressing proteobacteria in their gut, said method comprising the step of detecting the expression of the fimH gene in a stool sample of said subjects.
    Type: Application
    Filed: October 16, 2018
    Publication date: September 3, 2020
    Inventors: Alessandra CERVINO, Christophe BONNY, Jonathan PLASSAIS
  • GENES AND GENES COMBINATIONS BASED ON GENE MKNK1 PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM INFLAMMATORY DISEASE TO CYTOKINE TARGETING DRUGS (CYTD) OR ANTI-INFLAMMATORY BIOLOGICAL DRUGS
    Publication number: 20150240304
    Abstract: This invention refers to the field of human medicine and specifically to the diagnosis/prognosis of the responsiveness to a cytokine targeting drug (Cy TD) or an anti-inflammatory biological drug treatment of a subject suffering from an inflammatory disease.
    Type: Application
    Filed: January 25, 2012
    Publication date: August 27, 2015
    Inventors: Alessandra Cervino, Oana Popa-Nita, Jonathan Plassais